Advertisements promoting a number of Cabot Health products, which we published on the websites www.cabothealth.com.au and www.livercare.com.au, should not have been published.
In the advertisements we unlawfully made claims that the products could offer benefits in relation to serious health concerns including diabetes, diabetic neuropathy, cardiovascular disease, kidney disease, retinopathy, osteoporosis, hypertension or high blood pressure, heart attacks, strokes, kidney disease, blindness, cirrhosis, tumours, hemochromatosis, Wilson's disease, sclerosing cholangitis, and primary biliary cirrhosis, Parkinson's disease, diabetes, hepatitis, Alzheimer's disease, tumours, and cancer.
A complaint about the advertisement was recently upheld by the Complaints Resolution Panel. We provided no evidence to support the claims we made, and the Panel found that the claims were unlawful, misleading, and unverified and breached the Therapeutic Goods Advertising Code.
The Panel therefore requested that Cabot Health publish this retraction.
The full text of the Panel's determination can be found at: www.tgacrp.com.au/complaints